Investor profile
Amir Blatt
Corporate VC, Venture capital & Founding Partner at Almeda Ventures, Venture Investor, JJDC at Johnson & Johnson
Amir Blatt is a Venture Investor, JJDC at Johnson & Johnson, whose known portfolio counts 15 companies.
Is Amir Blatt a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIConsumerFoodHealthcare
- Focus
- BiotechCPGDiagnosticsDigital HealthFoodTechHealth EquityMedTechMedical Devices
Contacts
Affiliated funds' portfolios
Founding Partner at Almeda Ventures, whose known portfolio counts 6 companies
- Lumen
- TailorMed
- Sensi AI
- Augmedics
- BioProtect
- FlexDex
Venture Investor, JJDC at Johnson & Johnson, whose known portfolio counts 15 companies
- Rology
- Health In Her HUE
- Ready, Set, Food!
- Mamotest
- SwipeRx
- CareLoop Health
- 54 Collective
- Hamilton Health Box
- Alessa Therapeutics
- IndyGeneUS AI
- Lucia Health Guidelines
- Sensori
- and 3 more
Investor Profile
Founders in the listed sectors AI, Consumer, Food and Healthcare, and focus areas Biotech, CPG, Diagnostics and Digital Health fall inside that listing.
Stage-wise, the deals at Johnson & Johnson cluster around Growth, Pre-Seed and Seed rounds.
The firm portfolio and the focus above give founders context on whether Amir Blatt matches their raise.
Colleagues
Showing 20 of 24
Hirak Parikh
Principal, Venture Investments
Cambridge, United States
Christine Brennan
Vice President, Venture Investments
Cambridge, United States
Asish Xavier
Vice President
South San Francisco, United States
Wei Wu
Senior Director, Venture Investments, JJDC
San Francisco, United States
Nombuso Sibiya
New Venture Creation
Soweto, South Africa
Zykeyous Hawkins
Investor
Raleigh, United States
Minghe Chen
Investor
London, United Kingdom
Jaron M.
Co-Founder
Miami, United States
Patricia Sink
Venture Partner
United States
Hanna Harrush
Investor
Tel Aviv, Israel
Arno DePlus
Co-Founder
Brecht, Belgium
V. Kadir Kadhiresan
Vice President, Venture Investments
Boston, United States
Elizabeth Wu
Director
San Diego, United States
Amanda Greene
Venture Investments
Philadelphia, United States
Brian Imszennik
Director, Venture Investments
Riverton, United States
Sanjay Mistry
Vice President Venture Investments
San Diego, United States
Dong Wu
Head of AP Innovation Center
China
David Gruber
VP, Corporate Development & New Ventures
Teaneck, United States
Kyle O'Neil
Analyst, Venture Investments
Boston, United States
Nicole F.
Investment Partner
Los Angeles, United States
Frequently asked questions
Who is Amir Blatt?
Amir Blatt is a corporate venture investor and venture capital investor based in Israel, listed as Venture Investor, JJDC at Johnson & Johnson. The known portfolio of that firm counts 15 companies. That portfolio belongs to the firm, not to Amir Blatt personally.
What does Amir Blatt invest in?
Listed sectors include AI, Consumer, Food and Healthcare; listed focus areas include Biotech, CPG, Diagnostics and Digital Health. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Amir Blatt invest at?
Johnson & Johnson appears in Growth, Pre-Seed and Seed rounds across its known deals, and Amir Blatt is listed there as Venture Investor, JJDC. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Amir Blatt listed at?
Amir Blatt is listed as Venture Investor, JJDC at Johnson & Johnson. 24 other people in the database share a firm with Amir Blatt.
How do I contact Amir Blatt?
An email address, a phone number and a LinkedIn page are on file for Amir Blatt. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal